Sohouli Mohammad Hassan, Bagheri Seyedeh Elaheh, Fatahi Somaye, Rohani Pejman
Student Research Committee Department of Clinical Nutrition and Dietetics Faculty of Nutrition and Food Technology Shahid Beheshti University of Medical Sciences Tehran Iran.
Pediatric Gastroenterology and Hepatology Research Center Pediatrics Centre of Excellence Children's Medical Center Tehran University of Medical Sciences Tehran Iran.
Obes Sci Pract. 2024 Apr 26;10(3):e758. doi: 10.1002/osp4.758. eCollection 2024 Jun.
Overall, there is conflicting evidence regarding the beneficial effects of optimal lifestyle modification, particularly weight loss interventions, with nonalcoholic fatty liver disease (non-alcoholic fatty liver disease (NAFLD)). Therefore, this study investigated the effects of weight loss interventions on laboratory and clinical parameters in children and adolescents with NAFLD.
Original databases (PubMed/MEDLINE, Web of Science, SCOPUS, and Embase) were searched using standard keywords to identify all controlled trials investigating the effects of weight loss interventions among NAFLD children and adolescents. Pooled weighted mean difference and 95% confidence intervals were achieved by random-effects model analysis.
Eighteen eligible clinical trials were included in this systematic review and meta-analysis. The pooled findings showed that especially more intense weight loss interventions significantly reduced the glucose ( = 0.007), insulin ( = 0.002), homeostatic model assessment-insulin resistance (HOMA-IR) ( = 0.003), weight ( = 0.025), body mass index (BMI) ( = 0.003), BMI -score ( < 0.001), waist circumference (WC) ( = 0.013), triglyceride (TG) ( = 0.001), and aspartate transaminase (AST) ( = 0.027). However, no significant changes were found in total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), alanine transaminase (ALT), and hepatic steatosis grades (all > 0.05) following weight loss interventions.
Weight loss interventions had significant effects on NAFLD-related parameters including glucose, insulin, HOMA-IR, weight, BMI, BMI z-score, WC, TG, and AST.
总体而言,关于最佳生活方式改变,尤其是减肥干预措施对非酒精性脂肪性肝病(NAFLD)的有益影响,证据相互矛盾。因此,本研究调查了减肥干预措施对患有NAFLD的儿童和青少年的实验室及临床参数的影响。
使用标准关键词检索原始数据库(PubMed/MEDLINE、科学网、Scopus和Embase),以识别所有研究减肥干预措施对NAFLD儿童和青少年影响的对照试验。通过随机效应模型分析得出合并加权平均差和95%置信区间。
本系统评价和荟萃分析纳入了18项符合条件的临床试验。汇总结果显示,尤其是更强化的减肥干预措施显著降低了血糖(P = 0.007)、胰岛素(P = 0.002)、稳态模型评估-胰岛素抵抗(HOMA-IR)(P = 0.003)、体重(P = 0.025)、体重指数(BMI)(P = 0.003)、BMI z评分(P < 0.001)、腰围(WC)(P = 0.013)、甘油三酯(TG)(P = 0.001)和天冬氨酸转氨酶(AST)(P = 0.027)。然而,减肥干预后,总胆固醇、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、丙氨酸转氨酶(ALT)和肝脂肪变性分级均无显著变化(所有P > 0.05)。
减肥干预措施对与NAFLD相关的参数有显著影响,包括血糖、胰岛素、HOMA-IR、体重、BMI、BMI z评分、WC、TG和AST。